Recursos
Carer administration of as-needed subcutaneous medication for breakthrough symptoms in people dying at home: the CARiAD feasibility RCT
BMJ Open. 2025 Jun 12;15(6):e084476. doi: 10.1136/bmjopen-2024-084476.ABSTRACTOBJECTIVES: To determine if carer administration of as-needed subcutaneous medication for common breakthrough symptoms in people dying at home is feasible and acceptable in the UK, and if it would be feasible to test this intervention in a future definitive randomised controlled trial.DESIGN: We conducted a two-arm, parallel-group, individually randomised, open pilot trial of the intervention versus usual care, with a 1:1 allocation ratio, using convergent mixed methods.SETTING: Home-based care without 24/7 paid care provision, in three UK sites.PARTICIPANTS: Participants were dyads of adult patients and carers: patients in the last weeks of their…
Origen: Carer administration of as-needed subcutaneous medication for breakthrough symptoms in people dying at home: the CARiAD feasibility RCT – PubMed